Evidence map›Paper›PMID 38836884›Full record

ArticleAbdominal radiology (New York)2024

Updated endometrial cancer FIGO staging: the role of MRI in determining newly included histopathological criteria.

Ahmet Akçay, Mehmet Ali Gültekin, Fazılhan Altıntaş, Abdusselim Adil Peker, Serdar Balsak, Bahar Atasoy, Özlem Toluk, Hüseyin Toprak

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmet AkçayDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey. ahmetakcaymd@gmail.com.ORCID 0000-0001-7016-6004
Mehmet Ali GültekinDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
Fazılhan AltıntaşDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
Abdusselim Adil PekerDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
Serdar BalsakDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
Bahar AtasoyDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.
Özlem TolukDepartment of Biostatistics, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
Hüseyin ToprakDepartment of Radiology, Faculty of Medicine, Bezmialem Vakif University, +34093, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEndometrial cancer (EC) is among the prevalent malignancies in gynecology, showing an increasing occurrence and mortality rate. The updated 2023 FIGO staging integrates both histopathological and molecular analyses, which significantly impact the prognosis and treatment approaches. This research aims to examine the effectiveness of MRI in identifying essential histopathological tumor features, including histological subtype, grade, and lymphovascular space invasion.

methodsA total of 106 patients diagnosed with EC from February 2018 to December 2023 underwent preoperative pelvic MRI. Surgical procedures followed ESMO guidelines, with histopathological assessments using FIGO 2009 criteria. Two radiologists independently evaluated MRI images, measuring maximum tumor size, minimum tumor ADC value (using a free-hand ROI technique), and ADC tumor/myometrium ratio. MRI findings were compared with histopathological data.

resultsPeritoneal implant presence and tumor size exhibited significant differences between endometrioid adenocarcinoma (EAC) and non-endometrioid endometrial carcinoma (NEEC), with p values of < 0.001 and 0.003, respectively. Significant differences in age, tumor size, ADC tumor, and ADC tumor/myometrium between low-grade and high-grade tumors were observed, with p values of < 0.001, 0.004, 0.006, and 0.011, respectively. Increased tumor size, reduced ADC tumor, ADC tumor/myometrium, and pelvic peritoneal implant presence were significantly associated with LVSI, with p values of < 0.001, 0.001, 0.002, and 0.001, respectively. The AUC values for tumor size, ADC tumor, and ADC tumor/myometrium were 0.842, 0.781 and 0.747, respectively, in distinguishing between low and high-grade endometrial tumors. Similarly, obtained AUC values for predicting LVSI were 0.836, 0.719, and 0.696, respectively.

conclusionOur study emphasizes MRI's role in predicting tumor characteristics such as histological subtype, grade, and LVSI based on updated FIGO criteria. By highlighting the potential of MRI, this research contributes to our comprehension of improving diagnostic and clinical management for EC. Further multicenter studies are warranted to validate these findings and establish MRI's role in EC management.

Indexed as

Endometrial NeoplasmsMagnetic Resonance ImagingNeoplasm StagingAdultAgedAged, 80 and overFemaleHumansMiddle AgedNeoplasm GradingRetrospective StudiesEndometrial cancerFIGO classificationLymphovascular space invasionMRITumor gradeTumor subtype

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.